Gardner Lewis Asset Management’s Syneron Medical Ltd ELOS Stock Holding History
Bought
Maintained
Sold
Gardner Lewis Asset Management's ELOS Position: Q4 2017 in Review
Gardner Lewis Asset Management sold out of Syneron Medical Ltd (ELOS) in Q4 2017, closing a stake of 51,703 shares — an estimated $569K sold.
Gardner Lewis Asset Management first reported a position in ELOS in Q2 2017 and held it in 2 quarters. The position peaked at $17.9M in Q2 2017. 1 fund tracked by Wall St. Rank holds ELOS as of Q4 2017.
- Gardner Lewis Asset Management reported no remaining Syneron Medical Ltd position as of Q4 2017 after selling out during the quarter.
- Gardner Lewis Asset Management sold 51,703 Syneron Medical Ltd shares in Q4 2017, an estimated $569K.
- Gardner Lewis Asset Management first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 2 quarters.
- Gardner Lewis Asset Management's Syneron Medical Ltd position peaked at $17.9M in Q2 2017.
- 1 fund tracked by Wall St. Rank held Syneron Medical Ltd as of Q4 2017.
Based on Gardner Lewis Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.